Timing of removal of transluminal stents after endoscopic drainage of pancreatic fluid collections: a randomized controlled multicenter trial.

Timing of removal of transluminal stents after endoscopic drainage of pancreatic fluid collections: a randomized controlled multicenter trial. - REMOVE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39383

Enrollment

Registered

2012-05-21

Start date

2013-08-24

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic pseudocyst

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patient over 18 years old * PFC resolution (no remaining fluid collection larger than 3 cm) * Pigtail(s) positioned in remnant PFC * Abnormal PD on S-MRCP performed 12-16 weeks after drainage - ductal dilation (* 5 mm in body or tail) - ductal disruption - both ductal dilation and ductal disruption

Exclusion criteria

Exclusion criteria: * PFC complicating chronic pancreatitis * PFC after surgery * Recurrence of prior treated PFC * Acute-on-chronic pancreatitis

Design outcomes

Primary

Measure	Time frame
Recurrence of a PFC (>6 cm or symptomatic) proximal to the initial PD disruption after endoscopic drainage at or within 18 months after initial drainage	—

Secondary

Measure	Time frame
* Complications such as infection, pain that could be associated to leaving stents in situ * Number of spontaneous stent migrations before removal	—

Countries

Netherlands

Outcome results